Literature DB >> 24876864

Statins for patients with cardiogenic shock.

Sébastien Champion1.   

Abstract

Entities:  

Year:  2014        PMID： 24876864      PMCID： PMC4037645          DOI： 10.4070/kcj.2014.44.3.200

Source DB:  PubMed          Journal:  Korean Circ J        ISSN： 1738-5520            Impact factor:   3.243


× No keyword cloud information.
  10 in total

1.  Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.

Authors:  Philippe Garot; Nabil Bendaoud; Thierry Lefèvre; Marie-Claude Morice
Journal:  EuroIntervention       Date:  2010-08       Impact factor: 6.534

2.  Drug-eluting stents should not be used in ST-elevated myocardial infarction with cardiogenic shock.

Authors:  Sébastien Champion; Bernard Alex Gaüzère; Yannick Lefor
Journal:  Arch Intern Med       Date:  2012-11-12

3.  Hypophosphatemia in patients with cardiogenic shock.

Authors:  Sébastien Champion; Bernard Alex Gaüzère; David Vandroux
Journal:  J Crit Care       Date:  2012-10       Impact factor: 3.425

Review 4.  Shock in acute myocardial infarction: the Cape Horn for trials?

Authors:  Holger Thiele; Bachir Allam; Gilles Chatellier; Gerhard Schuler; Antoine Lafont
Journal:  Eur Heart J       Date:  2010-07-07       Impact factor: 29.983

5.  Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.

Authors:  Gregg C Fonarow; R Scott Wright; Frederick A Spencer; Paul D Fredrick; Wei Dong; Nathan Every; William J French
Journal:  Am J Cardiol       Date:  2005-09-01       Impact factor: 2.778

6.  Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction.

Authors:  Maria Koreny; Georg Delle Karth; Alexander Geppert; Thomas Neunteufl; Ute Priglinger; Gottfried Heinz; Peter Siostrzonek
Journal:  Am J Med       Date:  2002-02-01       Impact factor: 4.965

7.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

8.  Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.

Authors:  Frederick A Spencer; Jeanna Allegrone; Robert J Goldberg; Joel M Gore; Keith A A Fox; Christopher B Granger; Rajendra H Mehta; David Brieger
Journal:  Ann Intern Med       Date:  2004-06-01       Impact factor: 25.391

9.  Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.

Authors:  Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

10.  Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarction.

Authors:  Doo Sun Sim; Myung Ho Jeong; Kyung Hoon Cho; Youngkeun Ahn; Young Jo Kim; Shung Chull Chae; Taek Jong Hong; In Whan Seong; Jei Keon Chae; Chong Jin Kim; Myeong Chan Cho; Seung-Woon Rha; Jang Ho Bae; Ki Bae Seung; Seung Jung Park
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.